ORAMED PHARMACEUTICALS INC.·4

Aug 1, 8:00 PM ET

Rabinowitz Michael 4

4 · ORAMED PHARMACEUTICALS INC. · Filed Aug 1, 2022

Insider Transaction Report

Form 4
Period: 2022-07-28
Rabinowitz Michael
Chief Commercial Officer
Transactions
  • Award

    Common Stock

    2022-07-28+30,000139,468 total
Footnotes (1)
  • [F1]Represents Restricted Stock Units ("RSUs") that will vest in 3 installments as follows: 10,000 shall vest on each of January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION